+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

ROS-inducible DNA cross-linking agent as a new anticancer prodrug building block

ROS-inducible DNA cross-linking agent as a new anticancer prodrug building block

Chemistry 18(13): 3850-3854

(PDF emailed within 0-6 h: $19.90)

Accession: 055338370

Download citation: RISBibTeXText

PMID: 22378607

DOI: 10.1002/chem.201200075

Related references

Fluoride as an inducible DNA cross-linking agent for new antitumor prodrug. Organic & Biomolecular Chemistry 11(14): 2365-2369, 2013

Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs. Journal of the American Chemical Society 133(48): 19278-19281, 2012

Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104. Cancer Research 68(19): 7995-8003, 2008

A New Cross-Link for an Old Cross-Linking Drug: The Nitrogen Mustard Anticancer Agent Mechlorethamine Generates Cross-Links Derived from Abasic Sites in Addition to the Expected Drug-Bridged Cross-Links. Biochemistry 55(50): 7033-7041, 2017

Base specificity for DNA interstrand cross-linking induced by anticancer agent bizelesin. Archives Of Pharmacal Research (seoul). ): 191-196, 1996

Synthesis and antitumor activity evaluation of a novel combi-nitrosourea prodrug: Designed to release a DNA cross-linking agent and an inhibitor of O(6)-alkylguanine-DNA alkyltransferase. Bioorganic & Medicinal Chemistry 24(9): 2097-2107, 2016

Process for apparatus for forming solid particles by cross-linking drops of a cross-linkable material with a free-falling stream of cross-linking agent. Official Gazette of the United States Patent & Trademark Office Patents 1182(3): 1851, Jan 16, 1996

A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo. Biochemical Pharmacology 88(2): 158-168, 2014

Chemical cross-linking of chick oviduct progesterone-receptor subunits by using a reversible bifunctional cross-linking agent. Biochemical Journal 181(1): 201-213, 1979

HcRed, a genetically encoded fluorescent binary cross-linking agent for cross-linking of mitochondrial ATP synthase in Saccharomyces cerevisiae. Plos One 7(4): E35095-E35095, 2012

Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial. Cancer ChemoTherapy and Pharmacology 60(6): 851-861, 2007

Furan-oxidation-triggered inducible DNA cross-linking: acyclic versus cyclic furan-containing building blocks--on the benefit of restoring the cyclic sugar backbone. Chemistry 17(25): 6940-6953, 2011

Particle formation and aggregation-collapse behavior of poly(N-isopropylacrylamide) and poly(ethylene glycol) block copolymers in the presence of cross-linking agent. Journal of Materials Science. Materials in Medicine 15(5): 567-573, 2004

A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Research 67(9): 4303-4310, 2007

A highly GSH-sensitive SN-38 prodrug with an "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent. Chemical Communications, 2018